Hormone replacement therapy
- 31 August 1999
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 3 (4) , 495-499
- https://doi.org/10.1016/s1367-5931(99)80072-6
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- ERβ a Novel Estrogen Receptor Offers the Potential for New Drug DevelopmentTrends in Endocrinology & Metabolism, 1998
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Cloning and Characterization of Human Estrogen Receptor β IsoformsBiochemical and Biophysical Research Communications, 1998
- RaloxifeneDrugs & Aging, 1998
- Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal WomenNew England Journal of Medicine, 1997
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997
- ERβ: Identification and characterization of a novel human estrogen receptorFEBS Letters, 1996
- Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular DiseaseNew England Journal of Medicine, 1996
- A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal womenJournal of Bone and Mineral Research, 1996